Observational studyPloS one2024

Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis.

Marc Gurun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.